Cholesterol-lowering statins aren't just good for your heart — they may help your eyes too. A large retrospective study published in the British Journal of Ophthalmology found that statin users had a 15% lower risk of developing open-angle glaucoma at 5 years compared to non-users. The benefits persisted at 10 years, though somewhat attenuated, with a 10% reduced risk of new glaucoma diagnoses.

For patients already living with glaucoma, the findings were even more striking. Statin use was associated with significantly lower rates of surgical and laser interventions — suggesting these drugs may help slow disease progression and reduce the treatment burden. Specific statins like atorvastatin and rosuvastatin showed consistent protective effects.

By the Numbers:

• 15% lower risk of developing open-angle glaucoma at 5 years
• 60% lower risk for selective laser trabeculoplasty at 5 years
• 55% lower risk for minimally invasive glaucoma surgery at 5 years
• 36% lower risk for incisional glaucoma surgery at 5 years
• 11% lower risk for pressure-lowering eye drop prescriptions at 5 years

Why it matters: These findings suggest statins may serve as neuroprotective agents that complement — or even reduce reliance on — traditional glaucoma treatments, opening a new avenue for prevention and management of one of the world's leading causes of blindness.